The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Oncolytics Biotech Inc

TSX: ONC
Delayed quote

$0.74

Today's change-0.03 -3.90%
Updated November 20 3:59 PM EST. Delayed by at least 15 minutes.
 

Oncolytics Biotech Inc

TSX: ONC
Delayed quote

$0.74

Today's change-0.03 -3.90%
Updated November 20 3:59 PM EST. Delayed by at least 15 minutes.

Oncolytics Biotech Inc down $0.03

Oncolytics Biotech Inc closed sharply lower Monday, dropping $0.03 or 3.90% to $0.74. Over the last five days, shares have gained 21.31% and 179.25% year to date. Shares have outperformed the S&P TSX by 194.37% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.13
Updated November 20 3:59 PM EST. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2017Q2/2017Q1/2017Q4/2016
Fiscal Quarter Endvalues in $ millions unless otherwise notedSep 30, 201709/30/2017Jun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016
Revenue--------
Total other revenue--------
Total revenue0000
Gross profit--------
Total cost of revenue--------
Total operating expense3445
Selling / general / administrative0000
Research & development2323
Depreciation / amortization0000
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total1112
Operating income-3-4-4-5
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-3-4-4-5
Income after tax-3-4-4-5
Income tax, total0000
Net income-3-4-4-5
Total adjustments to net income--------
Net income before extra. items-3-4-4-5
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-3-4-4-5
Inc. avail. to common incl. extra. items-3-4-4-5
Diluted net income-3-4-4-5
Dilution adjustment----0--
Diluted weighted average shares140127121121
Diluted EPS excluding extraordinary itemsvalue per share-0.02-0.03-0.03-0.04
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.02-0.03-0.03-0.04